| Dr Mark D West, MD | |
|
624 Hospital Dr, Mountain Home, AR 72653-2955 | |
| (870) 508-1000 | |
| Not Available |
| Full Name | Dr Mark D West |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 42 Years |
| Location | 624 Hospital Dr, Mountain Home, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295894442 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 07428R (Louisiana) | Secondary |
| 207P00000X | Emergency Medicine | C-7164 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baxter Regional Medical Center | Mountain home, AR | Hospital |
| Fulton County Hospital | Salem, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baxter Emergency Group Pllc | 7810023108 | 15 |
News Archive
The Tecan Group, a leading global provider of laboratory instruments and solutions, and Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today the signing of a manufacturing and supply agreement for Enigma's ML instruments.
Those with severe chronic anemias need frequent blood transfusions to remain healthy, but such frequent transfusions can cause a potentially deadly buildup of iron in the body, leading to heart and liver failure. The traditional treatment to remove excess iron is so onerous that many patients choose to forgo it, putting their own lives at risk. The results of an international study on deferasirox, a new drug that may revolutionize the way chronic iron overload is treated, will be published in the May 1, 2006, issue of Blood, the official journal of the American Society of Hematology.
The Society of NeuroInterventional Surgery and M2S, a leading clinical registry provider, are pleased to announce the launch of the new Cerebral Aneurysm module for the NeuroVascular Quality Initiative (NVQI®), and the planned launch for the Cerebral Arteriovenous Malformations (AVMs) module in early October.
In the first study to comprehensively evaluate research priorities for patient safety in pediatrics, St. Jude Children's Research Hospital researchers and collaborators from other children's hospitals outlined 24 research priorities for improving pediatric patient care and safety.
Analysis of more than 8,000 women who participated in the world's largest study of two treatments for HER2-positive breast cancer reinforces other findings from the clinical trial showing that trastuzumab (Herceptin) should remain the standard of care for this cancer, says a Mayo Clinic researcher.
› Verified 3 days ago
| Entity Name | Baxter Emergency Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245560424 PECOS PAC ID: 7810023108 Enrollment ID: O20100325000569 |
News Archive
The Tecan Group, a leading global provider of laboratory instruments and solutions, and Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today the signing of a manufacturing and supply agreement for Enigma's ML instruments.
Those with severe chronic anemias need frequent blood transfusions to remain healthy, but such frequent transfusions can cause a potentially deadly buildup of iron in the body, leading to heart and liver failure. The traditional treatment to remove excess iron is so onerous that many patients choose to forgo it, putting their own lives at risk. The results of an international study on deferasirox, a new drug that may revolutionize the way chronic iron overload is treated, will be published in the May 1, 2006, issue of Blood, the official journal of the American Society of Hematology.
The Society of NeuroInterventional Surgery and M2S, a leading clinical registry provider, are pleased to announce the launch of the new Cerebral Aneurysm module for the NeuroVascular Quality Initiative (NVQI®), and the planned launch for the Cerebral Arteriovenous Malformations (AVMs) module in early October.
In the first study to comprehensively evaluate research priorities for patient safety in pediatrics, St. Jude Children's Research Hospital researchers and collaborators from other children's hospitals outlined 24 research priorities for improving pediatric patient care and safety.
Analysis of more than 8,000 women who participated in the world's largest study of two treatments for HER2-positive breast cancer reinforces other findings from the clinical trial showing that trastuzumab (Herceptin) should remain the standard of care for this cancer, says a Mayo Clinic researcher.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark D West, MD Po Box 1449, Mountain Home, AR 72654-1449 Ph: (870) 424-3181 | Dr Mark D West, MD 624 Hospital Dr, Mountain Home, AR 72653-2955 Ph: (870) 508-1000 |
News Archive
The Tecan Group, a leading global provider of laboratory instruments and solutions, and Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today the signing of a manufacturing and supply agreement for Enigma's ML instruments.
Those with severe chronic anemias need frequent blood transfusions to remain healthy, but such frequent transfusions can cause a potentially deadly buildup of iron in the body, leading to heart and liver failure. The traditional treatment to remove excess iron is so onerous that many patients choose to forgo it, putting their own lives at risk. The results of an international study on deferasirox, a new drug that may revolutionize the way chronic iron overload is treated, will be published in the May 1, 2006, issue of Blood, the official journal of the American Society of Hematology.
The Society of NeuroInterventional Surgery and M2S, a leading clinical registry provider, are pleased to announce the launch of the new Cerebral Aneurysm module for the NeuroVascular Quality Initiative (NVQI®), and the planned launch for the Cerebral Arteriovenous Malformations (AVMs) module in early October.
In the first study to comprehensively evaluate research priorities for patient safety in pediatrics, St. Jude Children's Research Hospital researchers and collaborators from other children's hospitals outlined 24 research priorities for improving pediatric patient care and safety.
Analysis of more than 8,000 women who participated in the world's largest study of two treatments for HER2-positive breast cancer reinforces other findings from the clinical trial showing that trastuzumab (Herceptin) should remain the standard of care for this cancer, says a Mayo Clinic researcher.
› Verified 3 days ago
Billy Gene Bisswanger, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 624 Hospital Dr, Mountain Home, AR 72653 Phone: 870-508-1000 Fax: 870-424-3089 | |
James M Mcdaniel Iii, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 624 Hospital Dr, Mountain Home, AR 72653 Phone: 870-424-7070 | |
Dr. David A Stills, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 624 Hospital Dr, Mountain Home, AR 72653 Phone: 870-508-1000 Fax: 870-424-3089 | |
Philip K Sadler, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 624 Hospital Dr, Mountain Home, AR 72653 Phone: 870-424-7070 | |
Melissa N Quevillon, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 624 Hospital Dr, Mountain Home, AR 72653 Phone: 870-424-3181 Fax: 870-424-3089 | |
Sharon Jamie Pritchard, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Drillers Rd, Mountain Home, AR 72653 Phone: 870-492-5995 Fax: 870-508-8900 | |
Spencer Charles Wright, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 624 Hospital Dr, Mountain Home, AR 72653 Phone: 870-508-1000 Fax: 870-424-3089 |